Menu
You need to sign in or sign up before continuing.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Can AvalonBay's Portfolio Strength Offset Development Setbacks?
Can AvalonBay's Portfolio Strength Offset Development Setbacks?

AvalonBay Communities AVB is well-poised to gain from healthy renter demand for its residential properties in the high barrier-to-entry regions of the United States. The company’s efforts to

5 Sector ETFs Rallying on Q2 Earnings Strength
5 Sector ETFs Rallying on Q2 Earnings Strength

The Q2 earnings season remains robust and continues to improve, with an above-average share of companies topping estimates and outlooks strengthening for both the current and upcoming periods. Among

Unum to Benefit From Growing Premium Amid Rising Expenses
Unum to Benefit From Growing Premium Amid Rising Expenses

Unum Group UNM holds the top position in the U.S. disability income market and ranks second in voluntary business. Unum's conservative pricing and reservation practices have contributed to overall

HOOD's July 2025 DARTs Jump: Is Product Suite Expansion Paying Off?
HOOD's July 2025 DARTs Jump: Is Product Suite Expansion Paying Off?

For July, Robinhood Markets, Inc. HOOD reported an increase in equity, options and crypto Daily Average Revenue Trades (DARTs) from the year-ago period. Equity DARTs in July were 2.7 million

AstraZeneca Rides Oncology Momentum With Blockbuster and New Drugs
AstraZeneca Rides Oncology Momentum With Blockbuster and New Drugs

AstraZeneca AZN is one of the leading drugmakers in the oncology space. Oncology sales (comprising around 43% of AstraZeneca‘s total revenues) rose 18% in the second quarter of 2025, generating $6.3

PPG Gains on Cost Actions and Acquisitions Amid Demand Softness
PPG Gains on Cost Actions and Acquisitions Amid Demand Softness

PPG Industries, Inc. PPG is benefiting from cost discipline, acquisitions and pricing actions amid headwinds from demand weakness, especially in Europe. Its second-quarter adjusted earnings of $2.22

Buy These 3 Top-Ranked High-Yield Bond Funds for Steady Gains
Buy These 3 Top-Ranked High-Yield Bond Funds for Steady Gains

For an average investor, high-yield bond mutual funds are the best to invest in bonds rated below investment grade, popularly known as junk bonds. This is because these funds hold a wide range of

Trinity Biotech's Redesigned CGM Sensor Favored by New Clinical Data
Trinity Biotech's Redesigned CGM Sensor Favored by New Clinical Data

Trinity Biotech plc TRIB announced compelling positive clinical trial results with respect to its next-generation continuous glucose monitoring (CGM) technology, CGM , on Tuesday. The trial data

How Much Upside is Left in Ardmore Shipping (ASC)? Wall Street Analysts Think 25.55%
How Much Upside is Left in Ardmore Shipping (ASC)? Wall Street Analysts Think 25.55%

Ardmore Shipping (ASC) closed the last trading session at $10.49, gaining 4.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

Does Astria Therapeutics (ATXS) Have the Potential to Rally 333.88% as Wall Street Analysts Expect?
Does Astria Therapeutics (ATXS) Have the Potential to Rally 333.88% as Wall Street Analysts Expect?

Shares of Astria Therapeutics, Inc. (ATXS) have gained 8.3% over the past four weeks to close the last trading session at $6.76, but there could still be a solid upside left in the stock if

Wall Street Analysts Predict a 151% Upside in Tourmaline Bio, Inc. (TRML): Here's  What You Should Know
Wall Street Analysts Predict a 151% Upside in Tourmaline Bio, Inc. (TRML): Here's What You Should Know

Tourmaline Bio, Inc. (TRML) closed the last trading session at $22.39, gaining 20.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set

Wall Street Analysts Think Harrow (HROW) Could Surge 53.24%: Read This Before Placing a Bet
Wall Street Analysts Think Harrow (HROW) Could Surge 53.24%: Read This Before Placing a Bet

Shares of Harrow (HROW) have gained 10.7% over the past four weeks to close the last trading session at $40.01, but there could still be a solid upside left in the stock if short-term price targets

Wall Street Analysts Believe Passage Bio (PASG) Could Rally 1415.15%: Here's is How to Trade
Wall Street Analysts Believe Passage Bio (PASG) Could Rally 1415.15%: Here's is How to Trade

Shares of Passage Bio, Inc. (PASG) have gained 31.5% over the past four weeks to close the last trading session at $7.59, but there could still be a solid upside left in the stock if short-term

Should You Buy Mettler-Toledo (MTD) After Golden Cross?
Should You Buy Mettler-Toledo (MTD) After Golden Cross?

Mettler-Toledo International, Inc. (MTD) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, MTD's 50-day simple moving average broke

Bears are Losing Control Over ESS Tech (GWH), Here's Why It's a 'Buy' Now
Bears are Losing Control Over ESS Tech (GWH), Here's Why It's a 'Buy' Now

A downtrend has been apparent in ESS Tech, Inc. (GWH) lately. While the stock has lost 7.1% over the past week, it could witness a trend reversal as a hammer chart pattern was formed in its last

How Much Upside is Left in The Pennant Group (PNTG)? Wall Street Analysts Think 31.17%
How Much Upside is Left in The Pennant Group (PNTG)? Wall Street Analysts Think 31.17%

The Pennant Group, Inc. (PNTG) closed the last trading session at $24.7, gaining 3.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set

Wall Street Analysts See a 28.68% Upside in West Pharmaceutical (WST): Can the Stock Really Move This High?
Wall Street Analysts See a 28.68% Upside in West Pharmaceutical (WST): Can the Stock Really Move This High?

West Pharmaceutical Services (WST) closed the last trading session at $246.2, gaining 11.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price

Elbit Systems Jumps on Record Earnings and a $1.6B Contract
Elbit Systems Jumps on Record Earnings and a $1.6B Contract

A powerful combination of a landmark European contract and a blockbuster earnings report has propelled Elbit Systems (NASDAQ: ESLT) into the spotlight, validating the company's strategy and

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The research service

Why Royal Philips (PHG) is a Top Momentum Stock for the Long-Term
Why Royal Philips (PHG) is a Top Momentum Stock for the Long-Term

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

Featuring daily updates

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Why Micron (MU) is a Top Momentum Stock for the Long-Term
Why Micron (MU) is a Top Momentum Stock for the Long-Term

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Here's Why Globe Life (GL) is a Strong Momentum Stock
Here's Why Globe Life (GL) is a Strong Momentum Stock

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The research service

Here's Why MKS (MKSI) is a Strong Momentum Stock
Here's Why MKS (MKSI) is a Strong Momentum Stock

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The popular research